PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-05-09

Date Title Company
09-May-2025 HOYA Vision Care launches the new ‘Sensity Colours’ stylish, light adaptive lenses in time for summer 2025 HOYA Vision Care
09-May-2025 CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025 ACCESS Newswire
09-May-2025 Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine Akero Therapeutics
09-May-2025 uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress uniQure
09-May-2025 PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF) PureTech Health plc
09-May-2025 Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab Tiziana Life Sciences
09-May-2025 Faith Bose Joins Health Net Connections LTD as UK Sales Director Health Net Connections Ltd
09-May-2025 Vesper Bio achieves enrolment milestone in Phase Ib/IIa trial of lead candidate VES001 for frontotemporal dementia Vesper Bio
09-May-2025 Theriva Biologics Announces Closing of $7.5 Million Public Offering Theriva Biologics
09-May-2025 Genmab Announces Financial Results for the First Quarter of 2024 Genmab
09-May-2025 ProQR Announces First Quarter 2025 Operating and Financial Results ProQR
09-May-2025 Acquisition Bolsters Aspire’s Strategic Portfolio Aspire Pharma Limited
09-May-2025 iOnctura commences randomized Phase I/II study in non-small cell lung cancer iOnctura
09-May-2025 Kelso Pharma builds for future growth with appointment of life sciences leader as Chief Operating Officer Kelso Pharma
09-May-2025 Life sciences growth requires payment rates to return to internationally comparable levels ABPI
09-May-2025 ABPI comment on UK-US trade agreement Association of the British Pharmaceutical Industry (ABPI)
09-May-2025 £5m project aims to make Liverpool global leader in biologics Liverpool School of Tropical Medicine
09-May-2025 Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025 Akero Therapeutics
09-May-2025 New Survey Reveals Enterprise AI Breakthroughs Advancing, But Business Impact Still Out of Reach Domino Data Lab
09-May-2025 Lonza Announces Results of the 2025 Annual General Meeting – All Motions Proposed by Board of Directors Approved Lonza Group AG